Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Return on Equity (2021 - 2023)

Historic Return on Equity for ADC Therapeutics (ADCT) over the last 3 years, with Q3 2023 value amounting to 0.0%.

  • ADC Therapeutics' Return on Equity changed 0.0% to 0.0% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.0%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.0% for FY2022, which is N/A changed from last year.
  • Latest data reveals that ADC Therapeutics reported Return on Equity of 0.0% as of Q3 2023, which was down 0.0% from 0.0% recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Return on Equity registered a high of 0.0% during Q3 2022, and its lowest value of 2829.7% during Q2 2021.
  • Its 3-year average for Return on Equity is 517.0%, with a median of 0.0% in 2022.
  • In the last 5 years, ADC Therapeutics' Return on Equity skyrocketed by 28297000bps in 2022 and then changed by 0bps in 2023.
  • Quarter analysis of 3 years shows ADC Therapeutics' Return on Equity stood at 3.26% in 2021, then soared by 100bps to 0.0% in 2022, then skyrocketed by 32bps to 0.0% in 2023.
  • Its Return on Equity stands at 0.0% for Q3 2023, versus 0.0% for Q2 2023 and 0.01% for Q1 2023.